BioSpace News Archive

An AI First: Deep Genomics Platform Reveals Wilson’s Disease Drug Candidate

Brendan Frey, founder and chief executive officer of Deep Genomics, called the discovery an “important milestone” for the company’s drug discovery program, as well as for Wilson’s disease patients.

September 26, 2019
·
3 min read
·
Alex Keown
Could You Start a Life Sciences Business?

Have you dreamed of running your own life sciences business? Doing so is not out of the reach of life sciences professionals. Here are all the possibilities you can choose from.

September 26, 2019
·
4 min read
·
By Katharine Hansen, PhD
Business

New NYC Life Sciences Campus Expected to Provide 1,400 Jobs

New York City’s life sciences community continues to boom as Deerfield Management Company, in partnership with LifeSci NYC and the New York City Economic Development Corporation, announced an initial $635 million investment to create a transformative life sciences campus in the Big Apple.

September 26, 2019
·
2 min read
·
Alex Keown
Drug Development

Jazz Pharma Hits the Mark with Another Narcolepsy Treatment

An investigational medicine in late-stage development by Jazz Pharmaceuticals hit the mark in treating cataplexy and excessive daytime sleepiness in adults with narcolepsy.

September 26, 2019
·
3 min read
·
Alex Keown
Job Trends

GSK and AstraZeneca’s PARP Inhibitors Will Flex Their Muscles at ESMO

PARP inhibitors will be taking center stage at the European Society of Medical Oncology Congress as rival drugmakers aim to show off data that supports broader use of the drug in treating various cancers.

September 26, 2019
·
2 min read
·
Alex Keown
Deals

Tacalyx Raises €7 Million in Seed Funding to Generate First in Class Anti-TACA Antibodies for Cancer Treatment

Tacalyx announced that it has successfully secured €7 million in seed funding.

September 26, 2019
·
9 min read
MM Patients Experience Longer Progression-Free Survival with REVLIMID

REVLIMID, or lenalidomide, describes itself as “a new chemotherapy-free treatment combination.”

September 26, 2019
·
4 min read
·
Elizabeth Glasure
Business

adMare Academy Announces New Executive Institute Cohort to Drive the Canadian Life Sciences Industry Forward

The adMare Academy is pleased to announce the latest Canadian life science leaders accepted into its Executive Institute -- a one-of-a-kind national executive development program custom designed to ensure that the Canadian life sciences sector has the management talent it needs to lead the world.

September 26, 2019
·
4 min read
Business

Ergomed plc: Interim results for the six months ended 30 June 2019

Ergomed plc, a company focused on providing specialised services to the global pharmaceutical industry, announces its unaudited interim results for the six months ended 30 June 2019.

September 26, 2019
·
5 min read
Business

Polarean notes statement from Amphion Innovations

Polarean Imaging plc, the medical-imaging technology company, with a proprietary drug-device combination product, notes the announcement made by its partner company, Amphion Innovations Plc that Amphion has agreed to amend the terms of the Loan Facility with Amphion’s debt provider.

September 26, 2019
·
1 min read